Alexander S Parker
Overview
Explore the profile of Alexander S Parker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
2598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nelson R, Seligson N, Bottiglieri S, Carballido E, Cueto A, Imanirad I, et al.
Cancers (Basel)
. 2024 Nov;
16(21).
PMID: 39518158
In the original publication [...].
2.
Kleinstern G, Boddicker N, OBrien D, Allmer C, Rabe K, Norman A, et al.
Blood Adv
. 2024 Feb;
8(9):2118-2129.
PMID: 38359367
High-count monoclonal B-cell lymphocytosis (HCMBL) is a precursor condition to chronic lymphocytic leukemia (CLL). We have shown that among individuals with HCMBL, the CLL-International Prognostic Index (CLL-IPI) is prognostic for...
3.
Abdelbaky S, Giacopelli B, Rabe K, Yamaguchi K, Wu Y, Yan H, et al.
Blood
. 2024 Jan;
143(17):1752-1757.
PMID: 38194687
Monoclonal B-cell lymphocytosis (MBL) progresses to chronic lymphocytic leukemia (CLL) requiring therapy at 1% to 5% per year. Improved prediction of progression would greatly benefit individuals with MBL. Patients with...
4.
Mobley E, Chen G, Xu J, Edgar L, Pather K, Daly M, et al.
J Surg Oncol
. 2023 Oct;
128(8):1285-1301.
PMID: 37781956
Introduction: We evaluated whether Medicaid expansion (ME) was associated with improved 2-year survival and time to treatment initiation (TTI) among patients with gastrointestinal (GI) cancer. Methods: GI cancer patients diagnosed...
5.
Mobley E, Guerrier C, Tfirn I, Gutter M, Vigal K, Pather K, et al.
J Racial Ethn Health Disparities
. 2023 Jan;
10(6):2826-2835.
PMID: 36596980
Introduction: We evaluated whether Medicaid expansion is associated with earlier stage at diagnosis for pancreatic cancer taking into account key demographic, clinical, and geographic factors. Methods: We obtained Surveillance, Epidemiology,...
6.
Eadon M, Cavanaugh K, Orlando L, Christian D, Chakraborty H, Steen-Burrell K, et al.
Contemp Clin Trials
. 2022 Jun;
119:106813.
PMID: 35660539
Rationale And Objective: APOL1 risk alleles are associated with increased cardiovascular and chronic kidney disease (CKD) risk. It is unknown whether knowledge of APOL1 risk status motivates patients and providers...
7.
Zhang D, Mobley E, Manini T, Leeuwenburgh C, Anton S, Washington C, et al.
Cancer
. 2022 May;
128(15):2978-2987.
PMID: 35608563
Background: Epidemiologic evidence reporting the role of frailty in survival among older adults with a prior cancer diagnosis is limited. Methods: A total of 2050 older adults (≥60 years old)...
8.
Mobley E, Tfirn I, Guerrier C, Gutter M, Vigal K, Pather K, et al.
J Am Coll Surg
. 2022 Feb;
234(1):75-84.
PMID: 35213464
Background: This study examined the effect of Medicaid expansion on 1-year survival of pancreatic cancer for nonelderly adults. We further evaluated whether sociodemographic and county characteristics alter the association of...
9.
Serie D, Myers A, Haehn D, Parker A, Bajalia E, Gonzalez G, et al.
Urol Oncol
. 2022 Feb;
40(4):168.e11-168.e19.
PMID: 35148948
Introduction: Limited data exists on utilization of protein post-translational modifications as biomarkers for clear cell renal cell carcinoma (ccRCC). We employed high-throughput glycoproteomics to evaluate differential expression of glycoprotein-isoforms as...
10.
Nelson R, Seligson N, Bottiglieri S, Carballido E, Cueto A, Imanirad I, et al.
Cancers (Basel)
. 2021 Apr;
13(7).
PMID: 33805415
Multi-gene assays often include and, in certain instances, may report associated toxicity risks for irinotecan, belinostat, pazopanib, and nilotinib. However, guidance for incorporating results into therapeutic decision-making is mostly lacking...